Abstract: A dynamically configurable antenna is integrated into a system configured to transmit and receive data. Antenna control software and/or hardware configures the antenna to transmit and receive data with different operating characteristics, depending on the communication needs of the system. The physical structure of the dynamically configurable antenna can be modified in order to perform data communications with specific frequency ranges, directionalities, transmission and/or amplification powers, and other operating characteristics generally associated with wireless RF communication.

Abstract: A dynamically configurable antenna is integrated into a system configured to transmit and receive data. Antenna control software and/or hardware configures the antenna to transmit and receive data with different operating characteristics, depending on the communication needs of the system. The physical structure of the dynamically configurable antenna can be modified in order to perform data communications with specific frequency ranges, directionalities, transmission and/or amplification powers, and other operating characteristics generally associated with wireless RF communication.

Abstract: A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.

Abstract: A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described.